United States v. Steven Sullivan

714 F.3d 1104, 2013 WL 2149910, 2013 U.S. App. LEXIS 10030
CourtCourt of Appeals for the Eighth Circuit
DecidedMay 20, 2013
Docket12-1754
StatusPublished
Cited by17 cases

This text of 714 F.3d 1104 (United States v. Steven Sullivan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Steven Sullivan, 714 F.3d 1104, 2013 WL 2149910, 2013 U.S. App. LEXIS 10030 (8th Cir. 2013).

Opinion

BYE, Circuit Judge.

Stephen Miles Sullivan was convicted by a jury of possession with intent to distribute a controlled substance analogue in violation of 21 U.S.C. §§ 802(32)(A), 813, and 841(a)(1)(C). The district court 1 sentenced Sullivan to 92 months of incarceration. Sullivan now appeals his conviction. We affirm.

After police seized powder containing 4-methylmethcathinone (mephedrone) from Sullivan’s vehicle during a traffic stop, the government charged Sullivan with possession with intent to distribute a controlled substance analogue.

At trial, Officer Jason Parsons, who had arrested Sullivan, testified about the stop. According to- Parsons, he had asked during the stop if there was anything illegal in the vehicle and Sullivan had responded that the vehicle contained bath powder. Trial Tr. 183. During a subsequent search of the *1106 vehicle, Parsons had seized, among other things, a 3" x 5" plastic bag containing 397 grams of a white powder, 100 2" x 2" seala-ble plastic bags, and sheets of two different kinds of labels corresponding to the size of the small plastic bags. Id. at 190-94. Pictures of the labels were submitted into evidence. See Appellee’s Add. 4, 5. The text on the first type of label read “Experience the Bliss ... Deluxe Bath Powder.” Id. at 4. The text on the second read “Pour 100-200 mg into Hot Bath. Kick back and Enjoy. Do not use more than $ pack per bath. Experience the Bliss____ Products not for human consumption. Keep out of reach of children. Distributors not responsible for misuse of product.” Id. at 5.

The white powder contained mephe-drone, a chemical analogue of methcathi-none. Trial Tr. 48. Methcathinone was at the time of the arrest and remains a Schedule I controlled substance. 2 Id. At the time of the arrest, Nebraska state law did not prohibit the salé of mephedrone. Id. at 148. Mephedrone was, however, illegal at the time as a controlled substance analogue under the Controlled Substance Analogue Enforcement Act (CSAEA) to the extent distributors intended it for human- consumption. Id. at 40, 53,90.

At trial, Drug Enforcement Agency (DEA) unit chief Liqun' Wong testified about the DEA’s knowledge regarding me-phedrone. According to Wong, at the time of the arrest, mephedrone had been an emerging drug which was widely distributed and abused on the illicit market. Id. at 50. Distributors purchased powder containing mephedrone in bulk and repackaged it into ready-to-use packages. Id. at 51. The packages were misleadingly labeled as bath salts and commonly sold in head shops. 3 Id. According to Wong, “no one” had purchased the mephedrone powder with the intent of using it in baths. Id. at 52. People consumed the mephedrone powder to obtain a pharmacological “high.” Id. at 49.

Wong also testified that even though mephedrone powder had been sold labeled as bath salts, the packaging indicated the powder had not been intended for use in baths. Id. at 52. Labeling on mephe-drone powder packages indicated the user could obtain a legal “high.” Id. In addition, manufacturers had not been required to list the ingredients of mephedrone powder on the package label. Id. at 42.

Officer Christopher Vigil, an undercover narcotics officer, also testified. According to Vigil, the Lincoln Police Department had received information that increasing numbers of people were ingesting bath salts to obtain a pharmacological “high.” Id. at 141. Vigil had investigated the sale of bath salts in head shops in the Lincoln area. Id. The head shops sold two types of products labeled as bath salts, large crystals and white powders. Id. at 141-42. Vigil believed the powder bath salts were being consumed to obtain a pharmacological “high.” Id. at 141. The head shops sold the powder bath salts in 2" x 2" seala-ble plastic bags bearing vague labels which did not list the ingredients of the contents. Id. at 142,147.

The jury ultimately convicted Sullivan and this appeal followed.

II

On appeal, Sullivan challenges the sufficiency of the evidence supporting *1107 his conviction. “We review de novo challenges to the sufficiency of the evidence.” United States v. Wells, 706 F.3d 908, 914 (8th Cir.2013) (citing United States v. Espinoza, 684 F.3d 766, 776 (8th Cir.2012)). “We ‘view the evidence in the light most favorable to the guilty verdict, granting all reasonable inferences that are supported by that evidence.’ ” United States v. Van Nguyen, 602 F.3d 886, 897 (8th Cir.2010) (quoting United States v. Milk, 447 F.3d 593, 598 (8th Cir.2006)). “We will reverse a conviction only if no reasonable jury could have found the defendant guilty beyond a reasonable doubt.” Wells, 706 F.3d at 914 (quoting United States v. Yang, 603 F.3d 1024, 1026 (8th Cir.2010)).

To convict Sullivan of possession of a controlled substance analogue with intent to distribute, the jury was required to find (1) Sullivan possessed mephedrone, a controlled substance analogue, (2) Sullivan knew he was in possession of a controlled substance analogue, and (3) Sullivan intended to distribute some or all of the controlled substance analogue for human consumption. Appellee’s Add. 6. Sullivan does not challenge the sufficiency of the evidence that mephedrone was a controlled substance analogue, that he possessed it, or that he intended to distribute it.

Sullivan contends the evidence was insufficient to prove he knew mephe-drone was a controlled substance analogue. Sullivan argues it was impossible for him to have known mephedrone was a controlled substance analogue at the time he was arrested because the DEA had not yet classified it as a controlled substance analogue. 4 The CSAEA does not, however, require the DEA to classify a substance as a controlled substance analogue before the substance falls under its purview. See 21 U.S.C. §§ 802(32)(A), 813.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Marques Smith
4 F.4th 679 (Eighth Circuit, 2021)
United States v. Eli Erickson
999 F.3d 622 (Eighth Circuit, 2021)
United States v. Charles Chastain
979 F.3d 586 (Eighth Circuit, 2020)
United States v. Javier Leon
924 F.3d 1021 (Eighth Circuit, 2019)
United States v. Allen Peithman, Jr.
917 F.3d 635 (Eighth Circuit, 2019)
United States v. Sandra Bart
888 F.3d 374 (Eighth Circuit, 2018)
United States v. Lorena Morales
813 F.3d 1058 (Eighth Circuit, 2016)
United States v. Earl Ramos
814 F.3d 910 (Eighth Circuit, 2016)
United States v. Gabriel Garcia-Hernandez
803 F.3d 994 (Eighth Circuit, 2015)
United States v. Ronald Riles
593 F. App'x 600 (Eighth Circuit, 2015)
United States v. Gross
60 F. Supp. 3d 1245 (S.D. Alabama, 2014)
United States v. Long
15 F. Supp. 3d 936 (D. South Dakota, 2014)
United States v. Johnson
745 F.3d 866 (Eighth Circuit, 2014)
United States v. Milton Rucker, Jr.
545 F. App'x 567 (Eighth Circuit, 2013)
United States v. Tracy Clemons
721 F.3d 563 (Eighth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
714 F.3d 1104, 2013 WL 2149910, 2013 U.S. App. LEXIS 10030, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-steven-sullivan-ca8-2013.